Skip to main content
MTL Cannabis Corp. logo

MTL Cannabis Corp. — Investor Relations & Filings

Ticker · MTLC ISIN · CA5539261068 CSE Manufacturing
Open in API
Filings indexed 643 across all filing types
Latest filing 2023-06-29 AGM Information
Country CA Canada
Listing CSE MTLC

About MTL Cannabis Corp.

https://www.mtlcorp.ca/

MTL Cannabis Corp. is a producer and distributor of cannabis products, recognized as a leader in the premium craft segment. The company operates as a "flower first" entity, specializing in the cultivation of high-THC, terpene-rich, indoor-grown cannabis flower and precision-rolled pre-rolls for the recreational market. MTL focuses on providing quality and accessibility to discerning consumers. Furthermore, the company maintains a significant presence in the medical cannabis sector, engaging in domestic distribution through subsidiaries and exporting branded products to international medical markets, including Australia.

Recent filings

Filing Released Lang Actions
Management information circular - English.pdf
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR' and includes detailed information about the upcoming Annual General Meeting (AGM) of Canada House Cannabis Group Inc. It contains the notice of the meeting, date, time, location, voting instructions, record date, and agenda items to be voted on by shareholders. It also references the management information circular, which is typically a proxy statement or detailed information provided to shareholders for the AGM. The document does not contain financial statements or detailed financial performance data itself but serves as the official notice and proxy solicitation material for the AGM. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, including notices and management information circulars.
2023-06-29 English
Other.pdf
M&A Activity Classification · 100% confidence The document is titled 'Second Restated Share Exchange Agreement' and is dated June 28, 2023. It involves multiple parties and details terms related to share exchange, amendments to previous agreements, and definitions of terms related to securities, warrants, and convertible debentures. The content is legal and contractual in nature, focusing on the terms and conditions of a share exchange transaction. There is no indication that this is a financial report, earnings release, management discussion, or regulatory filing unrelated to a transaction. The document is clearly related to a merger or acquisition activity, specifically a share exchange agreement, which fits the category of M&A Activity filings. The length (15,000 characters) and detailed contractual terms confirm it is the actual agreement document, not just an announcement or summary. Therefore, the appropriate classification is M&A Activity (TAR).
2023-06-29 English
Other.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Debenture Amending Agreement' and details amendments to a convertible debenture agreement between Canada House Cannabis Group Inc. and Archerwill Investments Inc. It includes specific terms about indebtedness, repayment conditions, warrants issuance, and other contractual provisions related to the debenture. There is no indication that this is a full annual or interim financial report, audit report, earnings release, or any other standard financial filing. Instead, it is a legal agreement amending the terms of a debt instrument, which relates to the company's capital structure and financing arrangements. Therefore, this document fits best under the category of Capital/Financing Update (CAP), as it updates the terms of the company's financing instruments.
2023-06-29 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Canada House Cannabis Group Inc. It announces a restatement of previously issued unaudited condensed consolidated financial statements and MD&A for the six months ended January 31, 2023 and 2022. The document details the nature of the restatement, including accounting errors and corrections to financial statement line items. It also includes a news release disseminated on June 21, 2023, describing the restatement and its impact. The document is not the full restated financial statements or MD&A themselves but a regulatory filing announcing and describing a material change related to financial reporting. It is a regulatory announcement about a material change rather than a full financial report or earnings release. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-06-28 English
News release - French.pdf
Regulatory Filings Classification · 90% confidence The document is a detailed technical review report of a mineral exploration project, specifically the Alces Lake Rare Earth Mineral Exploration Project. It includes extensive geological, exploration, environmental, and economic analysis sections, as well as appendices with drill hole data and analytical results. The content is technical and focused on mineral resource evaluation rather than corporate financial performance or regulatory filings. It does not correspond to any financial or corporate filing categories such as Annual Report, Earnings Release, or Management Reports. Instead, it is a specialized technical report related to mining exploration activities. Given the filing categories provided, none directly match a technical geological exploration report. The closest relevant category is Regulatory Filings (RNS) as a fallback for filings that do not fit other categories, since this is a regulatory-type document but not a financial or corporate governance filing.
2023-06-22 English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification filed by the Chief Financial Officer regarding the refiled interim financial report and MD&A for the interim period ended January 31, 2023. It is a certification letter under Form 52-109F2R, which is a regulatory attestation about the accuracy and fairness of the interim filings. The document does not contain actual financial statements or substantive financial data but rather certifies the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3183 characters), and it is clearly a certification, not the report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2023-06-22 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.